Grifols Biologicals, LLC

Quick facts

Marketed products

• Alphanate SD/HT · Hematology
  Alphanate SD/HT is a plasma-derived Factor VIII concentrate that replaces deficient clotting factor VIII to restore hemostasis in patients with hemophilia A.

Phase 3 pipeline

• Fibrin Sealant (FS) Grifols · Surgery / Hemostasis
  Fibrin sealant is a topical hemostatic agent that forms a fibrin clot by combining fibrinogen and thrombin to achieve rapid hemostasis at surgical sites.
• IGIV3I Grifols 10% · Immunology
  IGIV3I is an intravenous immunoglobulin (IVIG) product that provides passive immunity by delivering pooled human antibodies to modulate immune responses and provide immunoprotection.

Phase 2 pipeline

• Plasma-derived AT-III concentrate

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Grifols Biologicals, LLC portfolio CI brief
• Grifols Biologicals, LLC pipeline updates RSS